Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

EMBO, EMBC and the National Science Council of Taiwan Sign Cooperation Agreement

Published: Thursday, November 29, 2012
Last Updated: Thursday, November 29, 2012
Bookmark and Share
New ways of global scientific interaction have been created following a cooperation agreement between EMBO, the European Molecular Biology Conference (EMBC), and the National Science Council of Taiwan (NSC).

The agreement will allow Taiwanese scientists to participate in EMBO training programmes and activities. It also means that EMBO Courses & Workshops can take place at Taiwanese research institutes.

This is the first cooperation agreement of its kind between EMBO, EMBC and Taiwanese scientists, represented by NSC and Academia Sinica. The Taipei City-based Academia Sinica and NSC work together to create new opportunities for Taiwanese life scientists.


“EMBO promotes and encourages the development of the life sciences within Europe and beyond. We encourage the global mobility of scientists and we look forward to the increased scientific collaboration that this agreement will bring,” said EMBO Director Maria Leptin.

EMBO Associate Member and Academia Sinica President Chi-Huey Wong said: “EMBO is a leading organization that fosters new generations of life science researchers producing world-class scientific results. It is our delight to create great opportunities for young Taiwanese scientists to connect with the elite scientists of Europe.”

Representing the NSC, the cooperation agreement was signed by Minister Cyrus C.Y. Chu. He said: “This agreement opens up a gateway for Taiwanese life scientists to interact with some of the world’s brightest minds. We anticipate that more Taiwanese scientists will form affiliations with leading European life scientists because of this agreement.”

Under the terms of the agreement, scientists can apply for EMBO Short-Term and Long-Term Fellowships. Young Taiwanese group leaders will be eligible to benefit from the EMBO Young Investigator Programme, which provides outstanding young scientists with financial, academic and practical support to start up their first independent research laboratories.

Taiwanese scientists and EMBO will also cooperate in the organization of EMBO Courses & Workshops, which will help to spark collaborations between different scientific disciplines. Earlier this year, Academia Sinica and EMBO jointly organized the lecture course “Logic of Regulatory Circuits in Life Sciences” in Taipei City.

Conference organizers can apply for funding for plenary lectures given by EMBO Members or lectures given by EMBO Young Investigators at Taiwanese institutes and universities. Travel stipends will be available for Taiwanese scientists to attend EMBO Courses & Workshops and The EMBO Meeting.

The cooperation agreement will run for three years.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Endocrine Disruptors Impair Human Sperm Function
Endocrine disruptors may contribute to widespread fertility problems.
Tuesday, May 13, 2014
New Muscular Dystrophy Treatment Shows Promise in Early Study
A preclinical study has found that a new oral drug shows early promise for the treatment of muscular dystrophy.
Monday, September 09, 2013
EMBO Announces 52 New Members for 2013
EMBO announced today that 52 outstanding researchers in the life sciences were newly elected to its membership.
Tuesday, May 21, 2013
Scientific News
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!